Actively Recruiting
Caesar Foot Take-Home Validation Testing
Led by Liberating Technologies, Inc. · Updated on 2025-10-14
18
Participants Needed
1
Research Sites
43 weeks
Total Duration
On this page
Sponsors
L
Liberating Technologies, Inc.
Lead Sponsor
E
Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
Collaborating Sponsor
AI-Summary
What this Trial Is About
The rationale for this study is to conduct a take-home clinical trial to evaluate the impact of the bimodal Caesar foot in a real-world environment. Participants will take the device home and use it throughout their daily life for two months. A one-month baseline period, using their usual foot, will be completed both before and after the two-month period with the Caesar foot condition. Self-report surveys and performance-based measures will be collected in the clinic at the end of each condition. The intent of this study is to determine the Caesar foot's feasibility in a real-world environment. Data will be collected to understand impact to the user's daily life and physical activity through outcomes and participant feedback. The feedback obtained during this study will be essential to informing the design intended for commercialization.
CONDITIONS
Official Title
Caesar Foot Take-Home Validation Testing
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Have transtibial limb absence of one or both limbs
- Express interest in running but do not currently have a running blade
- Are at least 18 years of age
- Are at least six months post amputation
- Are classified as K3 or K4 ambulator status by a certified prosthetist
- Have an AMP score of at least 37
- Are capable of running safely as determined by a certified prosthetist
- Have a well-fitting socket as determined by a certified prosthetist
- Have adequate clearance between residual limb and ground for the Caesar foot
- Meet the foot size and weight class of one of the available Caesar prototypes
You will not qualify if you...
- Have present or past injuries to residual limb or other leg affecting ability
- Are non-English speaking due to limited interpreter access
- Are pregnant
- May be excluded for other issues like cognitive problems at investigator discretion
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Hanger Clinic
Austin, Texas, United States, 78758
Actively Recruiting
Research Team
J
Jennifer Johansson
CONTACT
B
Brianna Rozell
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
NON_RANDOMIZED
Model
CROSSOVER
Primary Purpose
TREATMENT
Number of Arms
3
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here